Search results for "Long term risk"

showing 1 items of 1 documents

Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboem…

2021

Background: The long-term risk for recurrent venous thromboembolism (VTE) during extended anticoagulation for a first unprovoked VTE is uncertain. Objectives: To determine the incidence of recurrent VTE during extended anticoagulation of up to 5 years in patients with a first unprovoked VTE. Methods: MEDLINE, EMBASE, and the Cochrane CENTRAL were searched to identify randomized trials and prospective cohort studies reporting recurrent VTE among patients with a first unprovoked VTE who were to receive anticoagulation for a minimum of six additional months after completing ≥3 months of initial treatment. Unpublished data on number of recurrent VTE and person-years, obtained from authors of in…

Pediatricsmedicine.medical_specialtypulmonary embolismanticoagulant therapy prognosis pulmonary embolism systematic review venous thromboembolism Anticoagulants Humans Prospective Studies Recurrence Risk Factors Pulmonary Embolism Venous Thromboembolismvenous thromboembolismMEDLINE030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicineanticoagulant therapy; prognosis; pulmonary embolism; systematic review; venous thromboembolism; Anticoagulants; Humans; Prospective Studies; Recurrence; Risk Factors; Pulmonary Embolism; Venous ThromboembolismRandomized controlled trialsystematic reviewRecurrenceRisk FactorslawHumansMedicineProspective Studies030212 general & internal medicinecardiovascular diseasesProspective cohort studyanticoagulant therapybusiness.industryIncidence (epidemiology)AnticoagulantsHematologymedicine.diseaseequipment and supplies3. Good healthPulmonary embolismLong term riskMeta-analysisprognosisbusinessVenous thromboembolismprognosi
researchProduct